Capricor Therapeutics, Inc. · NASDAQ:CAPR
State Street Corp reported a 5.90% stake in Capricor Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 7, 2026
State Street Corp reported a 5.90% stake in Capricor Therapeutics, Inc., 3,397,241 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).
- Stake
- 5.90%
- Shares
- 3,397,241
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.90% | 3,397,241 |
Source
Related
- Capricor Therapeutics, Inc.
- State Street Corp
- Capricor Therapeutics, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Oct 14, 2026
- Schedule 13G · Millennium Management LLC · Sep 14, 2026
- Schedule 13G · Millennium Management LLC · Aug 19, 2026
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Schedule 13G · Ra Capital Management, L.P. · Aug 3, 2026